ATXS vs NSC · rev $706.0K vs P/E 18, rev $6.46B
Astria Therapeutics Inc (ATXS) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
ATXS currently screens at market cap $382.1M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the ATXS and NSC stock pages for the full models.
Not investment advice.